scispace - formally typeset
P

Parisa Farnia

Researcher at Shahid Beheshti University of Medical Sciences and Health Services

Publications -  47
Citations -  809

Parisa Farnia is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 14, co-authored 47 publications receiving 734 citations. Previous affiliations of Parisa Farnia include Shahid Beheshti University.

Papers
More filters
Journal ArticleDOI

Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level

TL;DR: Evaluation of the differences between deadly bacilli and MDR or susceptible ones at the ultrastructural level using transmission electron microscopy was used to evaluate the genotyping patterns.
Journal ArticleDOI

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance

TL;DR: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases, and revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey are recommended.
Journal ArticleDOI

Improving Sensitivity of Direct Microscopy for Detection of Acid-Fast Bacilli in Sputum: Use of Chitin in Mucus Digestion

TL;DR: The chitin liquefaction and sedimentation method may provide better results in TB laboratories of developing countries than the N-acetyl-l-cysteine concentration, NaOCl overnight sedimentation, and direct smear microscopy methods.
Journal ArticleDOI

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

TL;DR: A major adverse effect such as neurologic side effects (depression, convulsions, consciousness, psychosis, and psychosis) can result in an increased chance of death among patients with MDR-TB.
Journal ArticleDOI

Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran

TL;DR: A majority of the MDR-TB patients in Iran can be cured with the use of appropriate treatment regimens, and an even greater success could be achieved by providing more second-line drugs.